Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... The Institute for Clinical and Economic Review (ICER) has published its final report on Spravato ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing Outpatient Behavioral Health Services is offering a new treatment. The treatment ...

They can also be used to treat snoring and nasal polyps, noncancerous growths in the nasal passages. Both the short-term and long-term use of nasal steroid sprays are thought to largely be safe for ...

They may discuss switching to a different treatment besides Lamictal or Spravato. Your doctor can give you more information. Is it safe to use a nasal corticosteroid or decongestant during ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved March 25, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

Milestone Pharmaceuticals Inc. announced that the FDA has set a PDUFA review goal date of March 27, 2025, for its nasal spray CARDAMYST™ (etripamil), aimed at treating Paroxysmal ...

The remaining 20% is their coinsurance. S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major depressive disorder ...